Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,891 | 907 | 99.9% |
| Education | $11.02 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,718 | 143 | $0 (2024) |
| Novo Nordisk Inc | $1,413 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,314 | 77 | $0 (2024) |
| Lilly USA, LLC | $1,278 | 88 | $0 (2024) |
| ABBVIE INC. | $1,167 | 75 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $742.53 | 49 | $0 (2023) |
| Gilead Sciences, Inc. | $669.43 | 32 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $660.31 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $593.12 | 36 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $474.47 | 35 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,324 | 122 | AstraZeneca Pharmaceuticals LP ($295.17) |
| 2023 | $2,375 | 125 | ABBVIE INC. ($438.83) |
| 2022 | $1,353 | 84 | GlaxoSmithKline, LLC. ($190.90) |
| 2021 | $1,426 | 93 | AbbVie Inc. ($191.02) |
| 2020 | $1,193 | 82 | GlaxoSmithKline, LLC. ($227.32) |
| 2019 | $1,637 | 123 | Novo Nordisk Inc ($262.18) |
| 2018 | $1,883 | 141 | GlaxoSmithKline, LLC. ($438.48) |
| 2017 | $1,711 | 139 | AstraZeneca Pharmaceuticals LP ($306.54) |
All Payment Transactions
909 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: Diabetes | ||||||
| 12/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.13 | General |
| Category: ANTIBIOTIC | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.37 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Cardio-renal | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: PAIN | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardio-renal | ||||||
| 11/27/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: NEUROSCIENCE | ||||||
| 11/25/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $31.16 | General |
| Category: HIV | ||||||
| 11/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Cardio-renal | ||||||
| 11/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.86 | General |
| Category: PSYCHIATRY | ||||||
| 11/08/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.10 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/05/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Insomnia | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/01/2024 | Merck Sharp & Dohme LLC | ISENTRESS (Drug), DELSTRIGO, PIFELTRO | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $20.90 | General |
| Category: Endocrinology | ||||||
| 10/29/2024 | ALK-Abello, Inc | Grastek (Drug), Odactra, Ragwitek | Food and Beverage | In-kind items and services | $27.63 | General |
| Category: Allergy and Immunology | ||||||
| 10/25/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $23.57 | General |
| Category: ANTIBIOTIC | ||||||
| 10/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.92 | General |
| Category: Cardio-renal | ||||||
| 10/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Diabetes Care | ||||||
| 10/18/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Diagnostics | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,349 | 1,926 | $253,547 | $117,365 |
| 2022 | 19 | 1,380 | 1,912 | $223,629 | $117,319 |
| 2021 | 30 | 1,756 | 2,241 | $159,249 | $111,246 |
| 2020 | 30 | 1,844 | 2,551 | $188,091 | $128,212 |
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 272 | 570 | $123,690 | $49,334 | 39.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 191 | 191 | $37,461 | $25,191 | 67.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 161 | 161 | $20,776 | $12,809 | 61.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 122 | 205 | $31,570 | $12,332 | 39.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 57 | 75 | $22,875 | $9,152 | 40.0% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 27 | 37 | $3,775 | $2,098 | 55.6% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 12 | 29 | $4,804 | $1,937 | 40.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,921 | $1,263 | 43.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 55 | 85 | $1,360 | $809.20 | 59.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 212 | 223 | $669.00 | $655.62 | 98.0% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 27 | 27 | $540.00 | $516.78 | 95.7% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 15 | 15 | $1,144 | $504.20 | 44.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 85 | 103 | $618.00 | $226.60 | 36.7% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 41 | 59 | $354.00 | $216.21 | 61.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 19 | 21 | $483.00 | $212.94 | 44.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 13 | 13 | $156.00 | $92.63 | 59.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 12 | 28 | $59.00 | $9.46 | 16.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 17 | 73 | $292.00 | $6.37 | 2.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 290 | 603 | $117,481 | $49,358 | 42.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 170 | 170 | $23,069 | $22,026 | 95.5% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 176 | 180 | $15,990 | $13,248 | 82.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 73 | 93 | $26,700 | $12,056 | 45.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 153 | $22,119 | $9,471 | 42.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 14 | $4,160 | $3,153 | 75.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 41 | 54 | $3,643 | $2,396 | 65.8% |
About Dr. Manuel Martin, M.D
Dr. Manuel Martin, M.D is a Family Medicine healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1710981402.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Manuel Martin, M.D has received a total of $13,902 in payments from pharmaceutical and medical device companies, with $2,324 received in 2024. These payments were reported across 909 transactions from 57 companies. The most common payment nature is "Food and Beverage" ($13,891).
As a Medicare-enrolled provider, Martin has provided services to 6,329 Medicare beneficiaries, totaling 8,630 services with total Medicare billing of $474,142. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Austin, TX
- Active Since 06/09/2005
- Last Updated 09/03/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1710981402
Products in Payments
- FARXIGA (Drug) $889.38
- JARDIANCE (Drug) $750.05
- TRELEGY ELLIPTA (Drug) $636.76
- Ozempic (Drug) $621.03
- Kerendia (Drug) $593.12
- VRAYLAR (Drug) $534.93
- TRULICITY (Drug) $401.30
- NURTEC ODT (Drug) $338.17
- SHINGRIX (Biological) $337.61
- SOLIQUA 100/33 (Biological) $336.01
- Rybelsus (Drug) $333.93
- ANORO (Drug) $290.53
- MOUNJARO (Drug) $282.09
- XARELTO (Drug) $281.91
- UBRELVY (Drug) $237.87
- REXULTI (Drug) $230.22
- Trintellix (Drug) $205.75
- XIFAXAN (Drug) $194.02
- INVOKANA (Drug) $186.54
- EMGALITY (Drug) $184.46
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Austin
Dr. Cynthia Brinson, M.d, M.D
Family Medicine — Payments: $533,082
Dr. David Wright, M.d, M.D
Family Medicine — Payments: $151,266
James Hahn, Md, MD
Family Medicine — Payments: $45,324
Rodolfo Alamia, Md, MD
Family Medicine — Payments: $44,627
Dr. Nomita Kim, Md, MD
Family Medicine — Payments: $39,549
Mr. Eric Perez, Fnp-C, FNP-C
Family Medicine — Payments: $32,768